Skip to main content
Erschienen in:

01.06.2019 | Case report

Bevacizumab/docetaxel/ramucirumab

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Arai M, et al. Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer. International Cancer Conference Journal 8: 114-117, No. 3, Jul 2019. Available from: URL: http://doi.org/10.1007/s13691-019-00366-6 - Japan Arai M, et al. Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer. International Cancer Conference Journal 8: 114-117, No. 3, Jul 2019. Available from: URL: http://​doi.​org/​10.​1007/​s13691-019-00366-6 - Japan
Metadaten
Titel
Bevacizumab/docetaxel/ramucirumab
Various toxicities: case report
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63624-6